ASSESSMENT OF BIOMARKERS FOR THERAPEUTIC DRUG MONITORING OF MTOR-INHIBITORS AFTER HEART TRANSPLANTATION

被引：0
|
作者：
Klein, S. [1 ]
Bittner, H. B. [1 ]
Dieterlen, M. -T. [1 ]
Garbade, J. [1 ]
Vollroth, M. [1 ]
Dhein, S. [1 ]
Mohr, F. W. [1 ]
Barten, M. J. [1 ]
机构：
[1] Herzzentrum Leipzig, Klin Herzchirurg, Leipzig, Germany
来源：
TRANSPLANT INTERNATIONAL | 2010年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
0170
引用
收藏
页码：57 / 57
页数：1
相关论文
共 50 条
  • [1] Novel Immunoassay for Therapeutic Drug Monitoring of mTOR-Inhibitors after Heart and Lung Transplantation
    Barten, M. J.
    Dieterlen, M. -T.
    Klein, S.
    Garbade, J.
    Vollroth, M.
    Dhein, S.
    Mohr, F. W.
    Bittner, H. B.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (04): : S55 - S55
  • [2] Real life experience with mTOR-inhibitors after lung transplantation
    Bos, S.
    De Sadeleer, L. J.
    Yserbyt, J.
    Dupont, L. J.
    Godinas, L.
    Verleden, G. M.
    Ceulemans, L. J.
    Vanaudenaerde, B. M.
    Vos, R.
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 94
  • [3] The influence of mTor-Inhibitors on HCV replication after liver transplantation
    Ecker, Eva-Maria
    Frey, Alexandra
    Piras-Straub, Katja
    Walker, Andreas
    Gerken, Guido
    Herzer, Kerstin
    HEPATOLOGY, 2014, 60 : 533A - 533A
  • [4] Real life experience in mTOR-inhibitors after lung transplantation
    Bos, Saskia
    De Sadeleer, Laurens
    Vanaudenaerde, Bart
    Yserbyt, Jonas
    Dupont, Lieven
    Godinas, Laurent
    Verleden, Geert
    Vos, Robin
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [5] MTOR-INHIBITORS REDUCE THE INCIDENCE OF CYTOMEGALOVIRUS INFECTION AFTER LIVER TRANSPLANTATION
    Hartl, J.
    Scherer, M. N.
    Loss, M.
    Farkas, S.
    Schnitzbauer, A.
    Baier, L.
    Schlitt, H. -J.
    Salzberger, B.
    Kirchner, G. I.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S222 - S223
  • [6] mTOR-Inhibitors and CMV Infection after Solid Organ Transplantation - Is CMV Prophylaxis Still Necessary?
    Andrassy, J.
    Hoffmann, V.
    Rentsch, M.
    Habicht, A.
    Stangl, M.
    Fischereder, M.
    Jauch, K. -W.
    Guba, M.
    TRANSPLANTATION, 2012, 94 (10) : 547 - 547
  • [7] Therapeutic drug monitoring of tacrolimus in early stage after heart transplantation
    Aidong, W
    Zhenjie, C
    Tong, L
    Lei, Z
    Yin, W
    Shanqi, Z
    Liping, T
    TRANSPLANTATION PROCEEDINGS, 2004, 36 (08) : 2388 - 2389
  • [8] Analytical and Pharmacological Aspects of Therapeutic Drug Monitoring of mTOR Inhibitors
    Pieri, Maria
    Miraglia, Nadia
    Polichetti, Giuliano
    Tarantino, Giovanni
    Acampora, Antonio
    Capone, Domenico
    CURRENT DRUG METABOLISM, 2011, 12 (03) : 253 - 267
  • [9] Outcomes after Early Initiation of mTOR-Inhibitors in Adult Cardiac Transplant Recipients
    Batra, J.
    Jennings, D.
    Garan, A. R.
    Truby, L. K.
    Latif, F.
    Restaino, S.
    Haythe, J.
    Yuzefpolskaya, M.
    Takeda, K.
    Takayama, H.
    Naka, Y.
    Colombo, P.
    Farr, M.
    Topkara, V. K.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (04): : S278 - S278
  • [10] mTOR-inhibitors and post-transplant diabetes mellitus: a link still debated in kidney transplantation
    Granata, Simona
    Mercuri, Silvia
    Troise, Dario
    Gesualdo, Loreto
    Stallone, Giovanni
    Zaza, Gianluigi
    FRONTIERS IN MEDICINE, 2023, 10
12345